Epstein-Barr virus (EBV) infection has a close correlation with NPC development, and patients with NPC have a distinct anti-EBV antibody profile, especially immunoglobulin A (IgA) antibodies [4]. This evidence concerns the gene CD79A and nasopharyngeal carcinoma.